4/22
06:39 am
kalv
KalVista Pharmaceuticals Appoints William C. Fairey to Board of Directors [Yahoo! Finance]
Medium
Report
KalVista Pharmaceuticals Appoints William C. Fairey to Board of Directors [Yahoo! Finance]
4/22
06:30 am
kalv
KalVista Pharmaceuticals Appoints William C. Fairey to Board of Directors
Medium
Report
KalVista Pharmaceuticals Appoints William C. Fairey to Board of Directors
4/11
08:06 am
kalv
KalVista Pharmaceuticals, Inc. (NASDAQ: KALV) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $35.00 price target on the stock.
Medium
Report
KalVista Pharmaceuticals, Inc. (NASDAQ: KALV) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $35.00 price target on the stock.
4/3
06:30 am
kalv
KalVista Pharmaceuticals to Present at 23rd Annual Needham Virtual Healthcare Conference
Low
Report
KalVista Pharmaceuticals to Present at 23rd Annual Needham Virtual Healthcare Conference
4/2
06:30 am
kalv
KalVista Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Low
Report
KalVista Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
3/18
06:48 am
kalv
KalVista Pharmaceuticals Presents Real-World Data on Burden of Treatment and HAE Attack Journey at the 2024 HAEi Regional Conference Americas [Yahoo! Finance]
Low
Report
KalVista Pharmaceuticals Presents Real-World Data on Burden of Treatment and HAE Attack Journey at the 2024 HAEi Regional Conference Americas [Yahoo! Finance]
3/18
06:30 am
kalv
KalVista Pharmaceuticals Presents Real-World Data on Burden of Treatment and HAE Attack Journey at the 2024 HAEi Regional Conference Americas
Low
Report
KalVista Pharmaceuticals Presents Real-World Data on Burden of Treatment and HAE Attack Journey at the 2024 HAEi Regional Conference Americas
3/12
06:56 am
kalv
KalVista Pharmaceuticals Awarded UK Promising Innovative Medicine (PIM) Designation for Sebetralstat [Yahoo! Finance]
Medium
Report
KalVista Pharmaceuticals Awarded UK Promising Innovative Medicine (PIM) Designation for Sebetralstat [Yahoo! Finance]
3/12
06:30 am
kalv
KalVista Pharmaceuticals Awarded UK Promising Innovative Medicine (PIM) Designation for Sebetralstat
Medium
Report
KalVista Pharmaceuticals Awarded UK Promising Innovative Medicine (PIM) Designation for Sebetralstat
3/11
06:32 am
kalv
KalVista Pharmaceuticals Reports Third Fiscal Quarter Results and Provides Operational Update [Yahoo! Finance]
High
Report
KalVista Pharmaceuticals Reports Third Fiscal Quarter Results and Provides Operational Update [Yahoo! Finance]
3/11
06:30 am
kalv
KalVista Pharmaceuticals Reports Third Fiscal Quarter Results and Provides Operational Update
High
Report
KalVista Pharmaceuticals Reports Third Fiscal Quarter Results and Provides Operational Update
3/8
06:37 am
kalv
KalVista Pharmaceuticals to Present HAE Attack Journey Data at 2024 HAEi Regional Conference Americas [Yahoo! Finance]
Medium
Report
KalVista Pharmaceuticals to Present HAE Attack Journey Data at 2024 HAEi Regional Conference Americas [Yahoo! Finance]
3/8
06:30 am
kalv
KalVista Pharmaceuticals to Present HAE Attack Journey Data at 2024 HAEi Regional Conference Americas
Medium
Report
KalVista Pharmaceuticals to Present HAE Attack Journey Data at 2024 HAEi Regional Conference Americas
3/7
06:43 am
kalv
KalVista Pharmaceuticals Announces Appointment of Benjamin L. Palleiko as Chief Executive Officer [Yahoo! Finance]
Medium
Report
KalVista Pharmaceuticals Announces Appointment of Benjamin L. Palleiko as Chief Executive Officer [Yahoo! Finance]
3/7
06:30 am
kalv
KalVista Pharmaceuticals Announces Appointment of Benjamin L. Palleiko as Chief Executive Officer
Low
Report
KalVista Pharmaceuticals Announces Appointment of Benjamin L. Palleiko as Chief Executive Officer
3/6
06:30 am
kalv
KalVista Pharmaceuticals to Participate in the Leerink Partners 2024 Global Biopharma Conference
Low
Report
KalVista Pharmaceuticals to Participate in the Leerink Partners 2024 Global Biopharma Conference
3/4
06:30 am
kalv
KalVista Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Low
Report
KalVista Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2/27
06:40 am
kalv
KalVista Pharmaceuticals Presents Data on Unmet Needs in HAE from a Patient Perspective at the 2024 American Academy of Allergy, Asthma & Immunology Annual Meeting [Yahoo! Finance]
Medium
Report
KalVista Pharmaceuticals Presents Data on Unmet Needs in HAE from a Patient Perspective at the 2024 American Academy of Allergy, Asthma & Immunology Annual Meeting [Yahoo! Finance]
2/27
06:30 am
kalv
KalVista Pharmaceuticals Presents Data on Unmet Needs in HAE from a Patient Perspective at the 2024 American Academy of Allergy, Asthma & Immunology Annual Meeting
Medium
Report
KalVista Pharmaceuticals Presents Data on Unmet Needs in HAE from a Patient Perspective at the 2024 American Academy of Allergy, Asthma & Immunology Annual Meeting
2/26
06:47 am
kalv
KalVista Pharmaceuticals Presents Additional Phase 3 KONFIDENT Data at the 2024 American Academy of Allergy, Asthma & Immunology Annual Meeting [Yahoo! Finance]
Medium
Report
KalVista Pharmaceuticals Presents Additional Phase 3 KONFIDENT Data at the 2024 American Academy of Allergy, Asthma & Immunology Annual Meeting [Yahoo! Finance]
2/26
06:30 am
kalv
KalVista Pharmaceuticals Presents Additional Phase 3 KONFIDENT Data at the 2024 American Academy of Allergy, Asthma & Immunology Annual Meeting
Medium
Report
KalVista Pharmaceuticals Presents Additional Phase 3 KONFIDENT Data at the 2024 American Academy of Allergy, Asthma & Immunology Annual Meeting
2/20
06:42 am
kalv
KalVista Pharmaceuticals Awarded UK Innovation Passport for Sebetralstat [Yahoo! Finance]
Medium
Report
KalVista Pharmaceuticals Awarded UK Innovation Passport for Sebetralstat [Yahoo! Finance]
2/20
06:30 am
kalv
KalVista Pharmaceuticals Awarded UK Innovation Passport for Sebetralstat
Medium
Report
KalVista Pharmaceuticals Awarded UK Innovation Passport for Sebetralstat
2/16
06:34 am
kalv
KalVista Pharmaceuticals to Present Phase 3 Sebetralstat Data at the 2024 American Academy of Allergy, Asthma & Immunology Annual Meeting [Yahoo! Finance]
Low
Report
KalVista Pharmaceuticals to Present Phase 3 Sebetralstat Data at the 2024 American Academy of Allergy, Asthma & Immunology Annual Meeting [Yahoo! Finance]
2/16
06:30 am
kalv
KalVista Pharmaceuticals to Present Phase 3 Sebetralstat Data at the 2024 American Academy of Allergy, Asthma & Immunology Annual Meeting
Low
Report
KalVista Pharmaceuticals to Present Phase 3 Sebetralstat Data at the 2024 American Academy of Allergy, Asthma & Immunology Annual Meeting